Phase II trial of pemetrexed in second line advanced/metastatic osteosarcomas.

Trial Profile

Phase II trial of pemetrexed in second line advanced/metastatic osteosarcomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2013

At a glance

  • Drugs Pemetrexed (Primary)
  • Indications Osteosarcoma
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 24 Jun 2011 Actual end date changed from Apr 2010 to Jun 2010 as reported by ClinicalTrials.gov.
    • 31 Aug 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
    • 31 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top